Phase 2 Fibrosis Lung Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
Fibrosis Lung
University of Wisconsin, Madison50 enrolled1 locationNCT06940427
Recruiting
Phase 2
4D-710 in Adult Patients With Cystic Fibrosis
Cystic Fibrosis Lung
4D Molecular Therapeutics30 enrolled20 locationsNCT05248230
Recruiting
Phase 1Phase 2
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Pseudomonas aeruginosaCystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088